On November 15, 2022, Davis Polk partners James Lin and Steve Wang will be among the speakers at BioCentury and BayHelix’s East-West BioPharma Summit. James and Steve will chair the “3rd…
On August 24, 2021, Davis Polk partner James Lin will be among the speakers at Asia Society Northern California’s “Executive Roundtable on Chinese Government Regulations on IPOs.” Topics…
Davis Polk partner James Lin was quoted in a recent Law.com International article discussing how U.S. firms can benefit from the strong pipeline of Asia-focused SPACs. “Even before the wave…
Davis Polk partner James Lin was quoted in a recent Asian Legal Business article discussing the resilience of Hong Kong capital markets amid the uncertainty of the COVID-19 pandemic. Lin…
On November 18, 2020, Davis Polk partner James Lin will speak at the 2020 Qiming Venture Partners 12th CEO Summit. Lin will present, “Strategies for a Successful IPO on the Hong Kong and…
On November 12, 2020, Davis Polk partner James Lin will moderate Biocentury’s virtual “C-Suite Bootcamp: HKEX/NASDAQ IPO Strategies.”The webcast will discuss the pros and cons of listing…
On August 27, 2020, Davis Polk partners Martin Rogers and James Lin and associates Joshua Friedman and Yuan Zheng spoke at the Association of Corporate Counsel’s “The HKSAR National…
Davis Polk partner James Lin will speak on BNY Mellon’s upcoming webcast, “Navigating the Path to IPO in Today’s Market Environment.” The panel will discuss insights and suggestions to…
Davis Polk partner James Lin will be among the speakers at the 6th China Healthcare Summit. Lin will speak on the “Capital Markets Showcase – Follow the Money” panel. Topics discussed…
Davis Polk partner James Lin will be among the speakers at Qiming Venture Partners’ 11th CEO Summit. Lin will participate on the “Picking Exit Venues: Options and Changing Landscapes”…
